Company Overview
Management
Board of Directors
Investors
Vision
Protein Optimization
ReCODE™ Technology
Site Matters
Intellectual Property
Articles
Benefits
Pipeline
Protein Optimization
AMBRX NEWS
Bristol-Myers Squibb and Ambrx Announce Collaboration for Novel Biologics Programs in Diabetes and Heart Failure
Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
© Copyright 2005-2012 Ambrx, Inc. All rights reserved.
